Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
Clinical trial NCT06003283 · RECRUITING
Trial details
- NCT number
- NCT06003283
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-09
- Primary completion
- 2027-12-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.